Moran Wealth Management’s Medpace MEDP Stock Holding History

Moran Wealth Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.84M	Buy	18,575 +5,730	+45%	+$2.64M	0.27%	123
2026 Q1	$6.17M	Sell	12,845 -582	-4%	-$298K	0.19%	168
2025 Q4	$7.54M	Sell	13,427 -1,064	-7%	-$604K	0.23%	137
2025 Q3	$7.45M	Sell	14,491 -363	-2%	-$158K	0.22%	129
2025 Q2	$4.66M	Sell	14,854 -2,074	-12%	-$623K	0.14%	193
2025 Q1	$5.16M	Buy	+16,928	New	+$5.69M	0.17%	166
2024 Q3	–	Sell	-590	Closed	-$243K	–	416
2024 Q2	$243K	Sell	590 -33,595	-98%	-$13.3M	0.01%	380
2024 Q1	$13.8M	Buy	+34,185	New	+$12M	0.45%	78

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Moran Wealth Management's MEDP Position: Q2 2026 in Review

Moran Wealth Management increased its Medpace (MEDP) stake by 45% in Q2 2026, buying an estimated $2.64M and bringing the position to 18,575 shares worth $9.84M. The position accounts for 0.27% of the portfolio, ranked #123.

Moran Wealth Management first reported a position in MEDP in Q1 2024 and has held it in 8 quarters since. The position peaked at $13.8M in Q1 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Moran Wealth Management held 18,575 shares of Medpace worth $9.84M as of Q2 2026.
Moran Wealth Management bought 5,730 Medpace shares in Q2 2026, an estimated $2.64M.
Medpace made up 0.27% of Moran Wealth Management's portfolio in Q2 2026, its #123 holding.
Moran Wealth Management first reported a position in Medpace in Q1 2024 and has held it in 8 quarters since.
Moran Wealth Management's Medpace position peaked at $13.8M in Q1 2024.
695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Moran Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.